ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $393,834 | -71.3% | 124,238 | -55.0% | 0.00% | -100.0% |
| Q2 2023 | $1,370,965 | -45.9% | 275,848 | -46.2% | 0.00% | -66.7% |
| Q1 2023 | $2,532,619 | -39.0% | 512,676 | -22.3% | 0.00% | -40.0% |
| Q4 2022 | $4,152,576 | -12.6% | 660,187 | +50.1% | 0.01% | -16.7% |
| Q3 2022 | $4,749,000 | +46.8% | 439,695 | +55.0% | 0.01% | +50.0% |
| Q2 2022 | $3,234,000 | -64.0% | 283,691 | -71.2% | 0.00% | -50.0% |
| Q1 2022 | $8,974,000 | +13.5% | 985,103 | +85.9% | 0.01% | +14.3% |
| Q4 2021 | $7,905,000 | +1253.6% | 529,815 | +2233.2% | 0.01% | +600.0% |
| Q3 2021 | $584,000 | -88.9% | 22,708 | -88.8% | 0.00% | -80.0% |
| Q2 2021 | $5,275,000 | +2061.9% | 202,263 | +3031.5% | 0.01% | – |
| Q3 2020 | $244,000 | -92.5% | 6,459 | -94.8% | 0.00% | -100.0% |
| Q4 2019 | $3,248,000 | – | 125,030 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |